These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 109703)

  • 21. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer.
    Buzdar AU; Smith TL; Powell KC; Blumenschein GR; Gehan EA
    Breast Cancer Res Treat; 1982; 2(2):163-9. PubMed ID: 6897369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trial.
    Hortobagyi GN; Buzdar AU; Frye D; Hug V; Fraschini G; Ames FC; Montague E; Gutterman JU; Martin RG
    Cancer; 1987 Dec; 60(11):2596-604. PubMed ID: 3315173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
    Soloway MS
    Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial response of local immunotherapy with Propionibacterium granulosum KP-45 in combined treatment of inflammatory breast carcinoma.
    Pluzanska A; Stempczynska J; Wolska H; Szmigielski S; Jeljaszewicz J; Pulverer G
    J Cancer Res Clin Oncol; 1988; 114(4):432-7. PubMed ID: 3410883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inflammatory breast carcinoma treated with a combination of chemotherapy and radiation therapy. Results of a randomized trial studying the therapeutic role of an immunotherapy with BCG (author's transl)].
    Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Vilcoq JR; Bataini JP; Calle R; Fenton J; Mathieu G; Rousseau J; Asselain B
    Bull Cancer; 1981; 68(2):171-86. PubMed ID: 7016224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.
    J Clin Oncol; 1988 Apr; 6(4):679-88. PubMed ID: 2895801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapy.
    Wiseman C; Jessup JM; Smith TL; Hersh E; Bowen J; Blumenshein G
    Cancer; 1982 Mar; 49(6):1266-71. PubMed ID: 6800632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens.
    Buzdar AU; Legha SS; Hortobagyi GN; Yap HY; Wiseman CL; Distefano A; Schell FC; Barnes BC; Campos LT; Blumenschein GR
    Cancer; 1981 Jun; 47(12):2798-802. PubMed ID: 7260870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemo immunotherapy of advanced breast cancer with BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Buzdar A; Burgess MA; Richman SP; Tashima CK; Schwarz M; Hersh EM
    Recent Results Cancer Res; 1977; (62):143-50. PubMed ID: 601328
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjuvant therapy of stage II, III breast cancer.
    Buzdar AV; Gutterman JU; Blumenschein GR; Tashima CK; Hortobágyi GN; Yap HY; Hersh EM; Gehan EA
    Recent Results Cancer Res; 1978; 68():123-8. PubMed ID: 379930
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemoimmunotherapy of small cell bronchogenic carcinoma.
    Holoye PY; Samuels ML; Smith T; Sinkovics JG
    Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy.
    Rabadi SJ; Haid M; Scanlon EF; Khandekar JD; Caprini JA; Oviedo MA; Cunningham MP; Grizenko KK; Cohen E
    J Surg Oncol; 1984 Aug; 26(4):233-7. PubMed ID: 6381884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, randomized Phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma.
    Blajman C; Balbiani L; Block J; Coppola F; Chacon R; Fein L; Bonicatto S; Alvarez A; Schmilovich A; Delgado FM
    Cancer; 1999 Mar; 85(5):1091-7. PubMed ID: 10091793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up adjuvant chemotherapy and chemoimmunotherapy for stage II and III carcinoma of the breast.
    Cohen E; Scanlon EF; Caprini JA; Cunningham MP; Oviedo MA; Robinson B; Knox KL
    Cancer; 1982 May; 49(9):1754-61. PubMed ID: 7042073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer.
    Yap HY; Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Krutchik AN; Benjamin RS; Gutterman JU; Bodey GP
    J Surg Oncol; 1979 Dec; 12(4):333-41. PubMed ID: 392197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Polychemotherapy associated with oral BCG in the treatment of advanced breast carcinoma. Preliminary observations of a controlled therapeutic trial].
    da Silva Neto JB; Fontes CE; Varella D
    AMB Rev Assoc Med Bras; 1981 Jul; 27(7):198-9. PubMed ID: 7036244
    [No Abstract]   [Full Text] [Related]  

  • 39. Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.
    Buzdar AU; Blumenschein GR; Gutterman JU; Tashima CK; Hortobagyi GN; Smith TL; Campos LT; Wheeler WL; Hersh EM; Freireich EJ; Gehan EA
    JAMA; 1979 Oct; 242(14):1509-13. PubMed ID: 470088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
    Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
    J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.